Markets Stocks Economy Crypto Earnings Banking Energy
Home Markets Feature
Markets · Exclusive

European ADRs edge higher as Nokia gains, Novo Nordisk slips

European ADRs edge higher as Nokia gains, Novo Nordisk slips
Markets · 2026
Photo · Marcus Devlin for Daily Digest Invest
By Marcus Devlin Equities Correspondent Sep 11, 2026 4 min read

European companies whose shares trade on US exchanges ticked higher late Friday morning, as the S&P Europe Select ADR Index rose 0.53% to 1,939.78. The modest gain masked sharp divergences among individual stocks, with Nokia climbing 3.1% while Novo Nordisk dropped 2.8%.

What are ADRs?

ADRs, or American Depositary Receipts, are a way for US investors to buy shares of foreign companies without dealing with overseas exchanges or currency conversions. Each ADR represents a certain number of shares in the underlying company, and they trade on US exchanges just like domestic stocks. The S&P Europe Select ADR Index tracks a basket of these instruments, giving a snapshot of how Europe's largest listed companies are performing in the US market.

Friday's move came amid a broader backdrop of uncertainty in global markets, with oil prices hovering near $100 a barrel and inflation concerns weighing on investor sentiment. European stocks have been under pressure recently, with the pan-European Stoxx 600 heading for its worst week since April as energy costs surged. The ADR index's rise, however, suggests some investors were finding bargains in European names.

Why Nokia rose and Novo Nordisk fell

Nokia, the Finnish telecom equipment maker, saw its ADR jump 3.1% on Friday. While the brief doesn't specify a catalyst, such moves often follow company-specific news or sector-wide optimism. Nokia has been a focus for investors due to its 5G infrastructure business and its efforts to expand into new markets like data centers and defense.

On the other side, Novo Nordisk, the Danish pharmaceutical giant known for its diabetes and obesity treatments, fell 2.8%. The drop could reflect profit-taking after a strong run, or concerns about competition in the weight-loss drug market. Novo Nordisk's ADRs have been among the most actively traded European names in the US, given the huge demand for its Wegovy and Ozempic products.

Such divergent moves are common in a broad index, where a single stock's news can outweigh the overall trend. For investors, it's a reminder that index-level gains or losses often hide significant variation beneath the surface.

What it means for investors

For everyday investors, the ADR index's rise is a sign that European equities are finding some footing, even as global markets face headwinds. The index's level of 1,939.78 is a reference point, but the real takeaway is the mixed performance: some sectors, like telecom, are gaining, while others, like pharma, are pulling back.

Investors holding ADRs should pay attention to the underlying fundamentals of each company, as well as currency movements. A stronger dollar can boost ADR returns for US investors, while a weaker euro can drag them down. The recent oil price surge, which has been a key driver of inflation fears, also affects European companies differently—energy producers benefit, while manufacturers and airlines face higher costs.

Looking ahead, market watchers will be watching for further clues on inflation and central bank policy. The European Central Bank has been raising interest rates to combat price pressures, and any hints of a pause could lift European stocks. Meanwhile, the ongoing conflict in Ukraine and its impact on energy supplies remain a wildcard.

For those considering European exposure, ADRs offer a convenient way to diversify, but they come with their own risks, including geopolitical and currency factors. As always, it's wise to focus on long-term fundamentals rather than short-term index moves.

In the broader context, Friday's modest gain in European ADRs comes as other global markets also show mixed signals. For instance, European stocks have been steady but are heading for their worst week since April as oil prices top $100. Similarly, oil above $100 is keeping pressure on South Korean stocks, with the KOSPI sliding 1.8%. These cross-market trends highlight how energy costs are rippling through global equities.

Investors should also keep an eye on upcoming US inflation data, which could set the tone for markets worldwide. As UAE stocks edged higher as investors await US inflation data, the same anticipation is likely to influence European ADRs in the coming sessions.

Ultimately, the ADR index's rise is a small positive, but it doesn't signal a clear direction. For now, the prudent approach is to stay diversified and keep a close watch on the factors—oil, inflation, and central bank policy—that are driving market moves.

More from this story

Next article · Don't miss

VVT Med Raises CA$1.9M, Settles Debt as Stock Slips

VVT Med raised CA$1.9 million in a private placement and settled some debt with new shares. The funds will support US commercialization, manufacturing, and working capital, even as the stock trades near CA$0.19.

Read the story →
VVT Med Raises CA$1.9M, Settles Debt as Stock Slips